|
ATE14047T1
(de)
*
|
1981-12-11 |
1985-07-15 |
Wyeth John & Brother Ltd |
Verfahren und vorrichtung zum gefrieren einer fluessigkeit.
|
|
US4942162A
(en)
|
1982-03-31 |
1990-07-17 |
University Of Tennessee Research Corporation |
Topical treatment of seborrheic dermatitis with ketoconazole
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4605642A
(en)
|
1984-02-23 |
1986-08-12 |
The Salk Institute For Biological Studies |
CRF antagonists
|
|
US4594329A
(en)
|
1984-05-14 |
1986-06-10 |
The Salk Institute For Biological Studies |
CRF analogs
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
US4661493A
(en)
|
1985-03-29 |
1987-04-28 |
Pfizer Inc. |
Tioconazole and related compounds for control of Herpes simplex virus
|
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US5016655A
(en)
|
1986-10-21 |
1991-05-21 |
C.A. Blockers, Inc. |
Cigarette manufacturing process
|
|
US4904582A
(en)
|
1987-06-11 |
1990-02-27 |
Synthetic Genetics |
Novel amphiphilic nucleic acid conjugates
|
|
US4814333A
(en)
|
1987-07-28 |
1989-03-21 |
The Trustees Of Dartmouth College |
Method for treatment of hypercortisolemic, depressed patients
|
|
US4925844A
(en)
|
1988-02-09 |
1990-05-15 |
Ici Americas Inc. |
Antagonizing the pharmacological effects of a benzodiazepine receptor agonist
|
|
US5006528A
(en)
|
1988-10-31 |
1991-04-09 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
|
DE3842007A1
(de)
|
1988-12-14 |
1990-06-21 |
Henkel Kgaa |
Fluessiges bis pastoeses, bleichmittelhaltiges waschmittel
|
|
US4974729A
(en)
|
1989-04-17 |
1990-12-04 |
Bristol-Myers Squibb Company |
Reminder system for taking medication
|
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
|
US5008528A
(en)
|
1989-07-14 |
1991-04-16 |
Logitech S.A. |
Invertible trackball
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
DE69133557D1
(de)
|
1990-08-29 |
2007-03-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US6326463B1
(en)
|
1994-12-12 |
2001-12-04 |
The Salk Institute For Biological Studies |
Cyclic CRF agonists
|
|
US6323312B1
(en)
|
1994-12-12 |
2001-11-27 |
The Salk Institute For Biological Studies |
Cyclic CRF antagonist peptides
|
|
US20030211157A1
(en)
|
1996-05-06 |
2003-11-13 |
Simon David Lew |
Semi-sol delivery blend for water soluble molecules
|
|
US5869474A
(en)
|
1997-05-16 |
1999-02-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Low dosage treatment for cocaine craving and withdrawal
|
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
NZ334627A
(en)
|
1999-03-12 |
2002-07-26 |
Horticulture & Food Res Inst |
A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
|
|
US6432989B1
(en)
|
1999-08-27 |
2002-08-13 |
Pfizer Inc |
Use of CRF antagonists to treat circadian rhythm disorders
|
|
GB0001449D0
(en)
|
2000-01-21 |
2000-03-08 |
Cortendo Ab |
Compositions
|
|
US6630449B2
(en)
|
2000-12-21 |
2003-10-07 |
David Wastchak |
Method for reducing the effect of nicotine addiction and dependancy
|
|
PT1411967E
(pt)
|
2001-06-26 |
2011-09-30 |
Univ North Carolina State |
Péptido bloqueador que atua sobre a secreção de células inflamatórias
|
|
GB0205253D0
(en)
|
2002-03-06 |
2002-04-17 |
Univ Gent |
Immediate release pharmaceutical granule compositions and a continuous process for making them
|
|
AU2003251829B2
(en)
|
2002-07-09 |
2009-12-10 |
Radical Therapeutix |
Method to inhibit ischemia and reperfusion injury
|
|
KR100503889B1
(ko)
|
2002-07-20 |
2005-07-26 |
한국과학기술연구원 |
옥틸로늄 브로마이드를 함유하는 항암제 흡수 증진제
|
|
CA2529857A1
(en)
|
2002-07-30 |
2004-02-05 |
Peter Migaly |
Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
|
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
|
US20040067986A1
(en)
|
2002-10-04 |
2004-04-08 |
Nathan Sassover |
Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer
|
|
US20050037983A1
(en)
|
2003-03-11 |
2005-02-17 |
Timothy Dinan |
Compositions and methods for the treatment of depression and other affective disorders
|
|
US20040185170A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Shubha Chungi |
Method for coating drug-containing particles and formulations and dosage units formed therefrom
|
|
US20080206138A1
(en)
|
2003-08-06 |
2008-08-28 |
Ilse Zolle |
Radiolabelled Phenylethyl Imidazole Carboxylic Acid Ester Derivatives
|
|
AU2004272437A1
(en)
|
2003-09-09 |
2005-03-24 |
Ono Pharmaceutical Co., Ltd. |
CRF antagonists and heterobicyclic compounds
|
|
US20050203130A1
(en)
|
2003-12-02 |
2005-09-15 |
Erik Buntinx |
Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
|
|
JPWO2005061508A1
(ja)
|
2003-12-22 |
2007-07-12 |
小野薬品工業株式会社 |
三環式複素環化合物およびその化合物を有効成分とする医薬
|
|
JP4399593B2
(ja)
|
2004-04-01 |
2010-01-20 |
国立大学法人 千葉大学 |
インフルエンザ脳症の検査法、及び、ヒト髄液中に発現するタンパク質からなるマーカ、診断薬、診断キット
|
|
JP5179174B2
(ja)
|
2004-05-28 |
2013-04-10 |
ノバルティス ファーマ アーゲー |
アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ［１，５−ａ］ピリジン誘導体
|
|
US7612088B2
(en)
|
2004-05-28 |
2009-11-03 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
EP1948238B1
(en)
*
|
2005-11-10 |
2013-08-28 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Compositions and methods for the treatment of addiction and other neuropsychiatric disorders
|
|
JP2009528289A
(ja)
|
2006-02-27 |
2009-08-06 |
ミシャロウ、アレクサンダー |
対抗適応を誘発することにより神経伝達物質系を調節する方法
|
|
EP2001866A2
(en)
|
2006-03-29 |
2008-12-17 |
Novartis AG |
Organic compounds
|
|
EA200900811A1
(ru)
|
2006-12-18 |
2009-12-30 |
Новартис Аг |
Имидазолы в качестве ингибиторов альдостеронсинтазы
|
|
US20080152709A1
(en)
|
2006-12-22 |
2008-06-26 |
Drugtech Corporation |
Clonidine composition and method of use
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
US8940315B2
(en)
|
2008-04-18 |
2015-01-27 |
Medtronic, Inc. |
Benzodiazepine formulation in a polyorthoester carrier
|
|
DE102008022221A1
(de)
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
|
AR072297A1
(es)
|
2008-06-27 |
2010-08-18 |
Novartis Ag |
Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
|
|
US8771735B2
(en)
|
2008-11-04 |
2014-07-08 |
Jazz Pharmaceuticals, Inc. |
Immediate release dosage forms of sodium oxybate
|
|
MX2011012202A
(es)
|
2009-05-15 |
2011-12-08 |
Novartis Ag |
Derivados de 5-piridin-3-il-1,3-dihidro-indol-2-ona y su uso como moduladores de a sintanasa de aldosterona y/o de cyp11b1.
|
|
NZ596302A
(en)
|
2009-05-15 |
2014-01-31 |
Novartis Ag |
Aryl pyridine as aldosterone synthase inhibitors
|
|
US8455522B2
(en)
|
2009-05-15 |
2013-06-04 |
Novartis Ag |
Benzoxazolone derivatives as aldosterone synthase inhibitors
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
US8519134B2
(en)
|
2009-11-17 |
2013-08-27 |
Novartis Ag |
Aryl-pyridine derivatives as aldosterone synthase inhibitors
|
|
WO2011064769A1
(en)
|
2009-11-24 |
2011-06-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and pharmaceutical compositions for the treatment of hot flashes
|
|
ES2472446T3
(es)
|
2009-11-30 |
2014-07-01 |
Novartis Ag |
Derivados de imidazol como inhibidores de aldosterona sintasa
|
|
JP5602250B2
(ja)
|
2010-01-14 |
2014-10-08 |
ノバルティス アーゲー |
副腎ホルモン修飾剤の使用
|
|
EP2582375A4
(en)
|
2010-06-16 |
2013-12-25 |
Embera Neurotherapeutics Inc |
COMPOSITIONS AND METHODS FOR TREATMENT OF ADDICTION, PSYCHIATRIC DISORDERS, AND NEURODEGENERATIVE DISEASE
|
|
US20120237482A1
(en)
|
2011-03-18 |
2012-09-20 |
Juan Rodriguez |
Methods for treatment of neurological disorders by modulation of microglial activation
|
|
US20150278438A1
(en)
|
2012-04-23 |
2015-10-01 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Genetic predictors of response to treatment with crhr1 antagonists
|
|
US20160008375A1
(en)
|
2013-03-01 |
2016-01-14 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations comprising quetiapine and escitalopram
|
|
WO2014210544A2
(en)
|
2013-06-27 |
2014-12-31 |
Cedars-Sinai Medical Center |
Adrenoceptors antagonists for the prevention and treatment of neurodegenerative conditions
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
CN104288385A
(zh)
|
2014-10-23 |
2015-01-21 |
朱道明 |
一种戒毒中药
|
|
CN108025008A
(zh)
*
|
2015-06-22 |
2018-05-11 |
安比拉神经疗法公司 |
用于治疗物质使用障碍、成瘾和精神病的组合物和方法
|
|
US9598459B2
(en)
|
2015-08-03 |
2017-03-21 |
Pop Test Oncology Llc |
Pharmaceutical compositions and methods
|
|
US20200016134A1
(en)
|
2016-02-16 |
2020-01-16 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for treating substance abuse disorders
|
|
CA3016335A1
(en)
|
2016-03-04 |
2017-09-08 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for treating addiction or substance use disorders
|
|
WO2018213713A1
(en)
|
2017-05-19 |
2018-11-22 |
Embera Neurotherapeutics, Inc. |
Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease
|